• No results found

[PDF] Top 20 Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy

Has 10000 "Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy" found on our website. Below are the top 20 most common "Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy".

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy

... base assessing the psychometric properties of the EQ-5D in adults with epilepsy on the whole is positive albeit ...generic measures (SF-6D and ...Duthie reported a relationship between the ... See full document

54

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular.

... Construct validity (convergent) between EQ-5D was generally good, and more evident at the index than at the health dimension level. This was the psychometric property for which there was more robust evidence, given the ... See full document

112

. Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Program

. Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.

... were reported at 2 weeks in the raltitrexed and the 5-FU+LV (fluorouracil + leucovorin) groups using the Rotterdam Symptom Checklist ...studies reported a lack of responsiveness in the ...al. ... See full document

36

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies

... was reported to be good, though data from one study showed that the EQ-5D correlated better with depression-specific measures and subscales than with anxiety-specific ones in people with ...validation ... See full document

49

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer.

... base used to assign HRQoL scores along the clinical pathway for patients with head and neck ...data used in these TAs do not satisfy the requirements of a submission to the ...cancer audit ... See full document

19

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia.

... The National Audit of Dementia (NAD) in its second and latest round (2012-2013) consisted of two modules, the hospital organisational checklist, and the casenote ...casenote audit consists of ... See full document

44

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes

... As discussed previously, the DH PROMS use the DHP which captures the day to day issues relating to managing diabetes. Hypoglycaemic events are a common consequence of insulin and weekly rates have been estimated at 0.82 ... See full document

57

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.

... The epilepsy NCA is in paediatrics, consequently the EQ-5D, which is recommended for adults, is potentially not relevant for this ...base assessing the psychometric properties of the EQ-5D in adults with ... See full document

82

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia

... other measures were identified and all recommended using the BPRS and the ...the patient-reported measures used are WEMWBS and s-WEMWBS, and a clinician-reported measure, HoNOS, ... See full document

42

Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National

Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE

... There are several disease-specific modules of the PedsQL (for asthma, arthritis, cancer, cardiac disease, diabetes) which are designed to be used in conjunction with the core modules. A recent publication provides ... See full document

59

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

... PROMs, clinical and photographic assessments at each time point and compared on an individual patient basis using measures of concordance including percentage agreement (with 95% confidence interval, ... See full document

68

Patient reported outcome measures for use in pregnancy and childbirth: a systematic review

Patient reported outcome measures for use in pregnancy and childbirth: a systematic review

... of assessing the effect of hyperemesis on pregnant women using the previously validated Hyperemesis Impact of Symptoms (HIS) tool, and with this information provid- ing advice tailored specifically to each woman’s ... See full document

8

Psychometric validation of patient-reported outcome measures assessing chronic constipation

Psychometric validation of patient-reported outcome measures assessing chronic constipation

... of measures should be allowed to ...PRO measures are more correlated with each other than can be explained by the variance shared with the ... See full document

10

Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective

Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective

... This figure shows the results of a hypothetical trial that compares the effects size after an effective intervention in a treatment group (T) to a control group (C) after an effective intervention. The treatment group ... See full document

8

Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight‐Control Clinical Trial and an Observational Cohort

Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight‐Control Clinical Trial and an Observational Cohort

... of patient index data 3 (RAPID3) is an index composed of only the 3 patient self-reported measures from the rheumatoid arthritis (RA) Core Data Set(3): physical function on a health assessment ... See full document

26

An alternative approach to implementing patient-reported outcome measures

An alternative approach to implementing patient-reported outcome measures

... a clinical service proved a management ...support clinical and other decisions. The various clinical groups in the case study with few excep- tions resorted to traditional methods of data ... See full document

9

Chiropractors’ views on the use of patient-reported outcome measures in clinical practice: a qualitative study

Chiropractors’ views on the use of patient-reported outcome measures in clinical practice: a qualitative study

... The qualitative interviews identified that chiropractors often had a lack of knowledge and engagement with PROMs, despite using them in clinical practice. It is also acknowledged in the findings that ... See full document

9

Patient involvement in the development of patient reported outcome measures: The developers’ perspective

Patient involvement in the development of patient reported outcome measures: The developers’ perspective

... of patient involvement and practical solutions should certainly not be completely disregarded as it helps developers involve patients within their ...a patient during ...on what is most ... See full document

10

<p>PROMs data: can it be used to make decisions for individual patients? A narrative review</p>

<p>PROMs data: can it be used to make decisions for individual patients? A narrative review</p>

... and cost of health care rise, it is argued that it is value, rather than the amount of care, which is considered most ...the cost of achieving those outcomes is considered fundamental in ...this. ... See full document

9

Assessment of patient-reported outcome measures in pleural interventions

Assessment of patient-reported outcome measures in pleural interventions

... There are limitations to this work. Patients were assessed from one hospital which is a tertiary referral centre for pleural disease. This study only assessed symptom change at 1 hour post procedure for ... See full document

6

Show all 10000 documents...